People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Other Technology, Biotechnology, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Longtail Ad Solutions, Inc | — | Other Technology | Series C | $93.6M | $1.3B | 2021 |
| Elion Therapeutics, Inc. | — | Biotechnology | Series B | $25.4M | $185.8M | 2024 |
| Axiom Health, Inc. | — | Healthtech | Series A | $4.8M | $43.9M | 2022 |
| Peak Gastroenterology ASC, LLC | — | Other Health Care | Pre-Seed | $702K | $14.2M | 2021 |
Jim Flynn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jim Flynn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ian Sigalow | 1 | 16 |
| Jonathan Leff | 1 | 11 |
| Anthony Tjan | 1 | 9 |
| David Reuter | 1 | 7 |
| Martin Heidecker | 1 | 6 |
| JON PHILLIPS | 1 | 5 |
| John Hamel | 1 | 5 |
| William Day | 1 | 3 |
| John D. Hamel | 1 | 3 |
| Timothy Stevens | 1 | 3 |
| Tim Stevens | 1 | 3 |
| Jim Hinrichs | 1 | 2 |
| Kieren Marr | 1 | 2 |
| Andrew Eisele | 1 | 2 |
| David Pashman | 1 | 1 |
| David Otten | 1 | 1 |
| Aroon Krishna | 1 | 1 |
| Teresa Danna | 1 | 1 |
| Kevin Cullinan | 1 | 1 |
| Owen Morris | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.